Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
CNS Drugs
|
May 26, 2016
A Review of Treatment Options for Progressive Supranuclear Palsy
Maria Stamelou, Günter Höglinger
Neurological Research and Practice
|
June 6, 2024
Diagnosis and treatment of Parkinson´s disease (guideline of the German Society for Neurology)
Günter Höglinger, , Claudia Trenkwalder
Current Treatment Options in Neurology
|
October 28, 2016
Current Treatment of Multiple System Atrophy
Sylvia Maaß, Johannes Levin, Günter Höglinger
Der Nervenarzt
|
October 6, 2023
[Treatment-Quo vadis neurodegeneration?]
Jonathan Vöglein, Johannes Levin, Günter Höglinger
Journal of Neurology
|
September 19, 2024
Definition and diagnosis of Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology
Franziska Hopfner, Günter Höglinger, , et al.
Acta Neuropathologica
|
June 4, 2025
Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component
Ulrich Müller, Günter Höglinger, Dennis W Dickson
Journal of Neurology
|
August 27, 2024
Akinetic crisis and withdrawal syndromes: guideline "Parkinson's disease" of the German Society of Neurology
Monika Pötter-Nerger, Matthias Löhle, Günter Höglinger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 4, 2026
How to treat cardiovascular autonomic failure in Parkinson's disease
Alessandra Fanciulli, Fabian Leys, Günter Höglinger, et al.
Plos One
|
November 18, 2014
Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation
Julius Bruch, Hong Xu, Anderson De Andrade, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 9, 2011
Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes
Maria Stamelou, Helena Christ, Alexander Reuss, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
CNS Drugs
|
May 26, 2016
A Review of Treatment Options for Progressive Supranuclear Palsy
Maria Stamelou, Günter Höglinger
Neurological Research and Practice
|
June 6, 2024
Diagnosis and treatment of Parkinson´s disease (guideline of the German Society for Neurology)
Günter Höglinger, , Claudia Trenkwalder
Current Treatment Options in Neurology
|
October 28, 2016
Current Treatment of Multiple System Atrophy
Sylvia Maaß, Johannes Levin, Günter Höglinger
Der Nervenarzt
|
October 6, 2023
[Treatment-Quo vadis neurodegeneration?]
Jonathan Vöglein, Johannes Levin, Günter Höglinger
Journal of Neurology
|
September 19, 2024
Definition and diagnosis of Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology
Franziska Hopfner, Günter Höglinger, , et al.
Acta Neuropathologica
|
June 4, 2025
Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component
Ulrich Müller, Günter Höglinger, Dennis W Dickson
Journal of Neurology
|
August 27, 2024
Akinetic crisis and withdrawal syndromes: guideline "Parkinson's disease" of the German Society of Neurology
Monika Pötter-Nerger, Matthias Löhle, Günter Höglinger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 4, 2026
How to treat cardiovascular autonomic failure in Parkinson's disease
Alessandra Fanciulli, Fabian Leys, Günter Höglinger, et al.
Plos One
|
November 18, 2014
Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation
Julius Bruch, Hong Xu, Anderson De Andrade, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 9, 2011
Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes
Maria Stamelou, Helena Christ, Alexander Reuss, et al.
Page
of 11